Clinical Trial Update: Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating HUEXC030 for pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• HUEXC030

Snippet

Sponsor: Orient Pharma Co., Ltd. | Conditions: Pulmonary Tuberculosis | Phase 2, Phase 3 | Status: COMPLETED